Page 8 - Curzon Energy News Today : Breaking News, Live Updates & Top Stories | Vimarsana

TRADING UPDATES: Beximco s India jab mire; Lamprell gets Aramco deal Wed, 28th Apr 2021 14:04 (Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News: Beximco Pharmaceuticals Ltd - Bangladesh-based generic pharmaceutical products and active pharmaceutical ingredients maker - Says agreement with Bangladeshi government and Serum Institute of India Pvt Ltd to deliver 30 million vaccine doses to Bangladesh is hit by India jabs export ban. Does not expect SII to be able to deliver remaining 23 million doses by end of June as India places ban on vaccine exports as cases there surge. The company will collaborate with SII to provide a revised supply schedule once the temporary export controls are relaxed. The expected positive impact on the current financial year, as outlined in the announcement on 5 November 2020, may therefore be mitigated, Beximco says. In addition, Beximco Pharma confirms

South africaNorth tynesideUnited kingdomWestern australiaSaudi arabiaCity ofAustralian capital territorySaudi arabianBeximco pharmaEric cunhaSerum institute of india pvt ltdRainbow rare earths ltdAlliance newsSaudi arabian oil coSoftbank group corp vision fundPharmaceuticals ltd